de Verneuil Vanina bought VIR
February 22, 2026 · Form 4 insider transaction
de Verneuil Vanina bought 55,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
55,000
Price
$0.00
Total value
N/A
Insiderde Verneuil Vanina
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 22, 2026
Filing dateFebruary 24, 2026
Shares owned after134,244
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.; Includes 1,034 shares of common stock acquired by the Reporting Person on November 28, 2025 pursuant to an employee stock purchase program.